0 CHECKOUT

PRODUCT FILTERS

REGION

56
21
13
12
8

COUNTRY

7
6
3
3
1

PRICE

79
112
129
220

PUBLISHED

1
4
22
220

PRODUCT TYPE

180
35
3
1
1

Drug Discovery

Bringing a new medicine to market is a process that cost about $1bn and can take up to 15 years. With the pharmaceutical industry facing multiple crises, budgets for research being squeezed and tough scientific challenges looming, academics and patients' groups are concerned we will not have the drugs necessary to treat future ills. More challenges will be posed by the imminent expiry of patents for some of the most lucrative drugs. The old model of drug discovery seems to be no longer efficient.

What is the future scenario of R&D? Keep track of the latest developments, trends and issues in this crucial sector of the huge pharmaceuticals industry with the publications listed under Research and Markets’ Drug Discovery category. You will find a wide range of academic and scientific textbooks on the latest R&D techniques, as well as top quality market reports with historical data and forecasts. Show Less
Read more

220 Products

Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019

About IHD IHD is an abnormal condition of the human body marked by narrowing or blocking of the arteries that supply blood to the heart. It results from the buildup of plaque in the arteries. The condition...

Published:  July 2015
Price:  From

Nonalcoholic steatohepatitis (NASH) - Pipeline Analysis

This report gives comprehensive insight on the various drugs being developed for the treatment of NASH. The report covers all the drugs being developed in various phases (Discovery, Preclinical & Clinical...

Published:  July 2015
Price:  From

Metabolomics Market by Technique, Application & by Indication - Global Forecast to 2019

In this report, the global metabolomics market is segmented based on techniques, applications, indications, and geography Based on techniques, the metabolomics market is classified into Gas Chromatography,...

Published:  July 2014
Price:  From

High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018

'High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology,...

Published:  February 2014
Price:  From

Brazil: Clinical Development Country Profile

This report provides insight into the clinical trial regulation and development environment, sponsor and service provider activities, and population “health status” for Brazil. METHODOLOGIES Authors...

Published:  January 2014
Price:  From

Circulating Tumour Cells (CTCs) and Circulating Nucleic Acids (CNAs) in Research, Clinical & Diagnostics and in Drug R&D: An Integrated Market Study of Developments, Growth Areas and Opportunities

Market findings from this integrated study are based on 'real world' laboratory data, provided by end-users who investigate Circulating Tumour Cells (CTCs) and Circulating Nucleic Acids (CNAs) in the...

Published:  May 2014
Price:  From

CRO Quality Benchmarking – Phase II/III Service Providers (6th edition)

In its 6th year, the “CRO Quality Benchmarking – Phase II/III Service Providers” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents...

Published:  January 2014
Price:  From

Risk – Reward of Developing a Herceptin Biosimilar – A Thorough Assessment

Herceptin exclusivity is expiring in major geographies and many Biosimilar players (both experienced and new entrant) are looking to have a share of this potential $6billion pie Herceptin sales are...

Published:  September 2012
Price:  From

Contract Research (Global) - Industry Report

The Contract Research (Global) Analysis provides a detailed overview of the Contract Research (Global) market and delivers a comprehensive individual analysis on the top 160 companies, including GRUENENTHAL...

Published:  September 2015
Price:  From

The Future of Biosimilars 2015

The Future of Biosimilars 2015 offers expert insight and opinion on the key issues facing the high risk, high reward biosimilars market: how the market is performing, where the market is headed and...

Published:  June 2015
Price:  From

2016 Life Science Global Funding & Lab Budget Outlook

The health of the life science tools industry is directly tied to the annual investments in research and development made by governments, private industry and investors. The economic climate, political...

Published:  June 2015
Price: 

Advances in the Orphan Drugs Market 2015

As well as outlining the regulatory environment for orphan drugs in key markets, this report highlights the areas where there is a significant unmet clinical need and provides an overview of the incentives...

Published:  May 2015
Price: 

CNS Drug News Issue

Generic competition for the 20mg version of Teva Pharmaceutical Industries' current multiple sclerosis market leader Copaxone will be available in the US by September. This, coupled with growing sales...

Published:  May 2015
Price: 

R&D Pipeline News - Technology Edition

R&D Pipeline News is your weekly tool for analysis of biopharmaceutical R&D It is available by monthly or annual subscription The annual subscription consists of 50 issues, the monthly of four or five...

Published:  May 2015
Price:  From

R&D Pipeline News - Therapeutic Area Edition

R&D Pipeline News is your weekly tool for analysis of biopharmaceutical R&D It is available by monthly or annual subscription The annual subscription consists of 50 issues, the monthly of four or five...

Published:  May 2015
Price:  From

R&D Drug Pipeline Database

PRODUCT DESCRIPTION Subscription to La Merie’s proprietary R&D Drug Pipeline Database provides online access to more than 12,000 project entries in all therapeutic areas and product categories Each...

Published:  May 2015
Price:  From

Frontiers in Computational Chemistry Volume 1

Computational chemistry is a very diverse field spanning from the development and application of linear free energy relationships (QSAR, QSPR), to electronic structure calculations, molecular dynamics...

Published:  March 2015
Price: 

Competitor Analysis: IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators

Competitor Analysis: IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators The Competitive Intelligence report about IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators...

Published:  March 2015
Price:  From

Analysis of America Movil SAB de CV

Analysis of America Movil SAB de CV. A complete and comprehensive analysis of America Movil SAB de CV, includes an overview of the industry the company operates in, a PEST Framework Analysis of the...

Published:  February 2015
Price:  From

Anti-Angiogenesis Drug Discovery and Development Vol. 2

The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular...

Published:  December 2014
Price: 
Loading Indicator

Our Clients